Spruce Biosciences, Inc. - stock earnings
SPRB Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -10.0 million USD | 2.9 million USD |
2023Q3 | -12.4 million USD | 3.1 million USD |
2023Q2 | -12.8 million USD | 2.2 million USD |
2023Q1 | -12.5 million USD | 2.0 million USD |
2022Q4 | -10.2 million USD | ? USD |
2022Q3 | -11.2 million USD | ? USD |
2022Q2 | -11.9 million USD | ? USD |
2022Q1 | -11.8 million USD | ? USD |
2021Q4 | -9.2 million USD | ? USD |
2021Q3 | -11.4 million USD | ? USD |
2021Q2 | -11.8 million USD | ? USD |
2021Q1 | -9.9 million USD | ? USD |
2020Q4 | -8.3 million USD | ? USD |
2020Q3 | -9.6 million USD | ? USD |
2020Q2 | -6.4 million USD | ? USD |
2020Q1 | -5.2 million USD | ? USD |
2019Q4 | -3.2 million USD | ? USD |
2019Q3 | -2.6 million USD | ? USD |
SPRB Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -47.9 million USD | 10.1 million USD |
2022 | -45.1 million USD | 2.0 million USD |
2021 | -42.7 million USD | ? USD |
2020 | -30.0 million USD | ? USD |
2019 | -13.2 million USD | ? USD |
2018 | -9.9 million USD | ? USD |
SPRB
Price: $0.70
52 week price:
Earnings Per Share: -1.24 USD
P/E Ratio: -3.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 65629
Market Capitalization: 33.9 million